CATHEDRAL MEDICAL GROUP — All Prescriptions & Medications — Page 11
Practice Code: H82042 | CHICHESTER, PO19 1XT
Showing results 501-550 of 736
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Metronidazole | 34 | 1,365 | £341 | -9.5% ▼ |
| Sodium fusidate | 34 | 660 | £108 | +515.7% ▲ |
| 34 | 1,400 | £480 | +31.8% ▲ | |
| Dalteparin sodium | 33 | 979 | £5.3K | +99.7% ▲ |
| Terbinafine hydrochloride | 33 | 1,358 | £700 | -46.6% ▼ |
| Tibolone | 33 | 1,505 | £144 | +7.8% ▲ |
| Ketoprofen | 33 | 4,300 | £218 | -8.0% ▼ |
| 33 | 140 | £920 | +18.6% ▲ | |
| Propiverine hydrochloride | 32 | 1,309 | £1.4K | +113.7% ▲ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 32 | 176.8K | £4.2K | +199.9% ▲ |
| Methylprednisolone acetate | 32 | 32 | £98 | -72.3% ▼ |
| Other toiletry preparations | 32 | 14.9K | £254 | -25.1% ▼ |
| 32 | 6,320 | £1.0K | -21.1% ▼ | |
| Losartan potassium with diuretic | 31 | 1,036 | £147 | +20.9% ▲ |
| Levomepromazine hydrochloride | 31 | 223 | £424 | +34.6% ▲ |
| Other compound vitamin/mineral formulation preparations | 31 | 1,320 | £120 | -3.3% ▼ |
| Travoprost | 31 | 155 | £548 | -34.2% ▼ |
| Bezafibrate | 30 | 1,200 | £290 | -44.3% ▼ |
| Norethisterone | 30 | 1,149 | £190 | -38.1% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 30 | 14.9K | £230 | +30.9% ▲ |
| Leflunomide | 30 | 900 | £53 | -20.7% ▼ |
| 30 | 2,320 | £91 | +77.5% ▲ | |
| 30 | 312 | £51 | -20.2% ▼ | |
| 30 | 1,050 | £2.3K | +46.3% ▲ | |
| Ciclesonide | 29 | 40 | £1.1K | +97.0% ▲ |
| Atomoxetine hydrochloride | 29 | 785 | £1.7K | -14.2% ▼ |
| Lacosamide | 29 | 5,459 | £489 | -46.0% ▼ |
| Levofloxacin | 29 | 289 | £313 | +462.7% ▲ |
| Powder thickener - starch based (0913161) | 29 | 8,280 | £222 | +101.9% ▲ |
| 29 | 3,343 | £5.6K | +57.6% ▲ | |
| RtS 1.3 kcal/g dessert style (fruit based) (0913051) | 28 | 73.4K | £1.6K | +438.0% ▲ |
| Prucalopride | 27 | 756 | £459 | -30.6% ▼ |
| Olmesartan medoxomil/amlodipine | 27 | 756 | £421 | +104.7% ▲ |
| Trifluoperazine | 27 | 7,500 | £3.4K | +79.0% ▲ |
| Levodopa/carbidopa/entacapone | 27 | 1,570 | £481 | -3.4% ▼ |
| Glucose | 27 | 3,075 | £276 | -48.1% ▼ |
| Denosumab | 27 | 27 | £4.8K | -0.8% vs avg |
| Hepatitis B | 27 | 27 | £300 | +155.1% ▲ |
| Sucralfate | 26 | 13.0K | £15.1K | +209.6% ▲ |
| Guanfacine | 26 | 728 | £1.6K | +1.2% vs avg |
| Dutasteride | 26 | 722 | £44 | -49.4% ▼ |
| Sodium fluoride | 26 | 1,326 | £131 | -21.6% ▼ |
| 26 | 275 | £889 | +90.6% ▲ | |
| 26 | 4,300 | £535 | +46.4% ▲ | |
| Alverine citrate | 25 | 1,520 | £56 | -39.6% ▼ |
| Daridorexant | 25 | 488 | £638 | +91.3% ▲ |
| Amantadine hydrochloride | 25 | 1,568 | £397 | -10.2% ▼ |
| Canagliflozin | 25 | 742 | £917 | -82.6% ▼ |
| Sodium feredetate | 25 | 13.7K | £376 | -12.7% ▼ |
| Tizanidine hydrochloride | 25 | 4,044 | £181 | -5.6% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.